These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32451413)

  • 1. Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer.
    Deng Y; Hu JC; He SH; Lou B; Ding TB; Yang JT; Mo MG; Ye DY; Zhou L; Jiang XC; Yu K; Dong JB
    Acta Pharmacol Sin; 2021 Jan; 42(1):149-159. PubMed ID: 32451413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage.
    Pei JP; Wang Y; Ma LP; Wang X; Liu L; Zhang Y; Jin R; Ren ZQ; Deng Y; Shen JK; Meng T; Yu K
    Acta Pharmacol Sin; 2023 Jun; 44(6):1290-1303. PubMed ID: 36650292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelin synthase 2 is a positive regulator of the CSF1R-STAT3 pathway in pancreatic cancer-associated macrophage.
    He S; Gu X; Yang J; Xu F; Hu J; Wang W; Huang Y; Lou B; Ding T; Zhou L; Ye D; Yu K; Dong J
    Front Pharmacol; 2022; 13():902016. PubMed ID: 36324684
    [No Abstract]   [Full Text] [Related]  

  • 4. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.
    Chen LM; Yang PP; Al Haq AT; Hwang PA; Lai YC; Weng YS; Chen MA; Hsu HL
    J Biomed Sci; 2022 Sep; 29(1):70. PubMed ID: 36109724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with
    Bouchard A; Sikner H; Baverel V; Garnier AR; Monterrat M; Moreau M; Limagne E; Garrido C; Kohli E; Collin B; Bellaye PS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMS2 siRNA inhibits pancreatic tumor growth by tumor microenvironment modulation.
    Jiang X; Yuan Z; Ding T; Yu K; Dong J
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113111. PubMed ID: 39255679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.
    Parveen S; Siddharth S; Cheung LS; Kumar A; Shen J; Murphy JR; Sharma D; Bishai WR
    Mol Oncol; 2021 May; 15(5):1330-1344. PubMed ID: 33682324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
    Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
    Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC
    Circ Res; 2009 Jul; 105(3):295-303. PubMed ID: 19590047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
    Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
    J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.
    Sami E; Paul BT; Koziol JA; ElShamy WM
    Cancer Res; 2020 Mar; 80(5):1102-1117. PubMed ID: 31911557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
    Lee C; Kim S; Jeong C; Cho I; Jo J; Han IH; Bae H
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.
    Zhang Q; Le K; Xu M; Zhou J; Xiao Y; Yang W; Jiang Y; Xi Z; Huang T
    Int Immunopharmacol; 2019 Nov; 76():105864. PubMed ID: 31480004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis.
    Zonneville J; Colligan S; Grant S; Miller A; Wallace P; Abrams SI; Bakin AV
    Int J Cancer; 2020 Oct; 147(8):2279-2292. PubMed ID: 32452014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.
    Li Y; Huang T; Lou B; Ye D; Qi X; Li X; Hu S; Ding T; Chen Y; Cao Y; Mo M; Dong J; Wei M; Chu Y; Li H; Jiang XC; Cheng N; Zhou L
    Eur J Med Chem; 2019 Feb; 163():864-882. PubMed ID: 30580239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
    Chen M; Liu H; Hong B; Xiao Y; Qian Y
    FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
    Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.